Loading...

CLINICAL HIV AND AIDS JOURNAL (ISSN:2633-5476)

CMV Pneumonitis with a Cavitary Lung Lesion: A Rare Presentation in HIV

Shamaei M1*, Tabarsi P2, Nadji A3, Dorudinia A4

1 Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran (Islamic Republic of)
2 Mycobacteriology Research Center, NRITLD,  Shahid Beheshti University of Medical Sciences, Tehran, Iran (Islamic Republic of)
3 Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran (Islamic Republic of)
4 Pediatric Respiratory Disease Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran (Islamic Republic of)

CitationCitation COPIED

Shamaei M, Tabarsi P, Nadji A, Dorudinia A. CMV pneumonitis with a cavitary lung lesion: a rare presentation in HIV. Clin HIV AIDS J. 2018 Dec;1(1):105

Abstract

Cytomegalovirus is a major cause of morbidity and mortality in patients with AIDS and immunosuppressed patients. Diagnosis of CMV disease often requires tissue biopsy with histologic evidence of viral inclusions and inflammation. This paper reports a rare case of an HIV-infected patient with a history of anemia, who presented with a cavitary lesion in the lung that has diagnosed as CMV pneumonitis, associated with CMV colitis that eventually the patient developed Acute Inflammatory Demyelinating Polyneuropathy (AIDP). 

Keywords

CMV; Pneumonia; Cavitary; HIV

Introduction

Cytomegalovirus (CMV) pneumonia is among the leading causes of morbidity and mortality in immune suppressed patients [1,2].

In HIV patients, the presence of CMV in bronchoalveolar lavage (BAL) specimen is not usually indicated for CMV pneumonia [3,4] and definitive diagnosis relies on documented evidence of CMV infection in the pulmonary tissue specimen [5].

On the other hand, pneumonia, with CMV as the only pathogen in pulmonary tissue, has rarely occurred in patients with HIV [6,7]. Chest radiographic findings vary, including reticular or ground glass opacities, alveolar infiltration or nodular opacities but cavitary lesions are rare [8].

This paper reports an HIV-infected patient with a history of anemia, the cavitary lesion due to CMV pneumonitis, associated with CMV colitis that eventually developed acute inflammatory demyelinating polyneuropathy (AIDP). 

Case report

A 61-year-old HIV-positive woman was admitted to Masih Daneshvari Hospital, Tehran with a three-month history of anemia, weakness, dyspnea, cough, fever, chills, bone pain, weight loss (less than 10% of total body weight) and loss of appetite. A complete workup was done for fever, weakness, and anemia that was not diagnostic, Chest x-ray was suspicious to a small cavitary in the left upper lobe, but several sputum smears for M.tb were negative. Finally, HIV was confirmed by western blot test and she was referred to our center to rule out TB/AIDS. She has divorced 15 years ago, life-long non-smoker, non- drug abuser and without any exposure to TB. The patient seemed doesn’t have any risk factor for HIV

Considering her critical condition with fever and dyspnea plus HIV status (520000 copies/ml HIV plasma viral load with a CD4 count of 342), highly active antiretroviral therapy (HAART) including efavirenz, lamivudine, zidovudine were administered. Sputum and BAL smears/culture for acid-fast bacillus (AFB) was negative and also real-time PCR for MTB complex was negative too. Regarding chest X-ray finding including interstitial infiltration and cavitary lesion, bronchoscopy procedure was performed that was not diagnostic. BAL smear and culture were negative for bacterial and fungal pathogen and immune staining results for Pneumocystis jiroveci were negative.

The patient then underwent computed tomography (CT) guided the biopsy. Pathological study of the detected lesion revealed diffuse interstitial pneumonia in which pneumocytes lining thickened alveolar septa were enlarged with intra nuclear and intra cytoplasmic inclusion. Immuno staining of the specimen was positive for CMV (Figure 1). Tissue culture was negative for MTB complex using Ziehl–Neelsen staining and PCR. Moreover, she received colonoscopy because of abdominal pain that revealed the gross involvement of large intestine which was confirmed by pathology studies.

Virology studies showed positive plasma PCR for CMV (690 copies/mL CMV viral load) and positive CMV antigen (pp65-Ag), so ganciclovir (intravenous) was started and her condition improved gradually.

Brain CT scan was performed to exclude toxoplasmosis. PCR detection of Toxoplasma and Parvovirus B19 were also negative in a blood sample. 

Two months later, she developed weakness of lower extremities that progressed to upper extremities during three days and eventually as a result of the weakness of respiratory muscles, she was incubated in intensive care unit. At this time CMV PCR of plasma became negative. Cerebrospinal fluid (CSF) analysis was negative for herpes simplex virus 1&2 (HSV-1 and HSV-2), varicella-zoster virus (VZV), and CMV. CSF cell count was zero and protein was 50 mg/dl. In India ink preparation no cryptococcus identified. She gradually developed severe pancytopenia and acute renal failure and unfortunately, she was expired with the clinical picture of septic shock. Nerve conduction velocity tests for definitive diagnosis of AIDP could not be performed due to the patient’s critical condition.


Figure 1: A) Nonspecific type of chronic interstitial pneumonia. Enlarged CMV-infected alveolar pneumocytes can be appreciated. Inset shows Monoclonal antibody to CMV, B) CT scan of lung reveals left upper lobe cavitary lesion

Discussion

Lung involvement is one of the main causes of morbidity and mortality in HIV patients [9]. Because of immune insufficiency states, infections are predominant and isolation of more than one organism is common during the autopsy, especially in advanced AIDS cases [10]. Although in endemic countries, tuberculosis is the most common etiology [11], Lung cavitary lesion with CMV is rare [12,13]. In one study, among 21 AIDS patients with cytopathologic evidence of CMV pneumonitis, only one patient had a cavitary lesion [10]. However, differentiation between CMV disease and bacterial infection still remains controversial. 

Salomon et al. [8] have reported 41% in-hospital mortality of CMV pneumonia treated with specific anti-CMV, other studies confirm the poor outcome of CMV pneumonia in HIV patients [14]. 

An autoimmune process, acute inflammatory demyelinating polyneuropathy (AIDP), may be associated with CMV infection in advanced HIV [15,16]. 

The classic presentation is a symmetric acute motor weakness in more than one extremity, coupled with that in the absence of long tract signs and sensory loss is suggestive of AIDP [17,18].

This is a case of CMV pneumonia with cavitary lesion confirmed by biopsy while another opportunistic infection in the lung especially mycobacterial infection was ruled out. Also, the extrapulmonary involvement of CMV was verified in this patient as positive plasma PCR for CMV and large intestine involvement. With Regard to the appropriate response to ganciclovir, unconfirmed AIDP and negative CMV assay in cerebral fluid, it is suggested that the patient was expired because of immune reconstitution syndrome after HAART administration. Cavitated pulmonary lesion is not common in HIV patients. Also, CMV pneumonitis with cavitary lesion makes this patient rare case of CMV infection in HIV positive, immune compromised person.  

Conflict of Interest

The authors declare that they have no competing interests.

References

  1. Jain M, Duggal S, Chugh TD. Cytomegalovirus infection in non-immunosuppressed critically ill patients. J Infect Dev Ctries. 2011Aug;5(8):571-579.
  2. Beam E, Germer JJ, Lahr B, Yao JDC, Limper AH, et al. Cytomegalovirus(CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia. Clin Transplant. 2018 Jan;32(1). 
  3. Bozzette SA, Arcia J, Bartok AE, McGlynn LM, McCutchan JA, etal. Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease. J Infect Dis. 1992 Jan;165(1):93-98.
  4. Miles PR, Baughman R, Linnemann C. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. CHEST Journal.1990 May;97(5):1072-1076.
  5. Drew WL. Cytomegalovirus infection in patients with AIDS. Journal of Infectious Diseases. 1988 Aug;158(2):449-456.
  6. Rodriguez-Barradas MC, Stool E, Musher DM, Gathe J, Goldstein J, etal. Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis. 1996 Jul;23(1):76-81.
  7. Herry I, Cadranel J, Antoine M, Meharzi J, Michelson S, et al. Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS: a new clinical entity? Clin Infect Dis. 1996 Apr;22(4):616-620.
  8. Salomon N, Gomez T, Perlman DC, Laya L, Eber C, et al. Clinical features and outcomes of HIV-related cytomegalovirus pneumonia.AIDS.1997 Mar;11(3):319-324.
  9. Meduri GU, Stein DS. Pulmonary manifestations of acquired immunodeficiency syndrome. Clinical infectious diseases. 1992Jan;14(1):98-113.
  10. Aviram G, Fishman JE, Sagar M. Cavitary lung disease in AIDS : etiologies and correlation with immune status. AIDS Patient Care STDS. 2001 Jul;15(7):353-361.
  11. Afessa B, Green W, Chiao J, Frederick W. Pulmonary Complications of HIV Infection Autopsy Findings. Chest. 1998 May;113(5):1225-1229.
  12. McGuinness G, Scholes JV, Garay SM, Leitman BS, McCauley DI, etal. Cytomegalovirus pneumonitis: spectrum of parenchymal CT findings with pathologic correlation in 21 AIDS patients. Radiology.1994 Aug;192(2):451-459.
  13. Park S, Jang HJ, Kim YW, Park BS, Kim HK, et al. Cavitary LungLesion in a Patient with Systemic Lupus Erythematosus: An UnusualManifestation of Cytomegalovirus Pneumonia. J Rheum Dis. 2015Dec;22(6):387-390.
  14. Klatt EC, Shibata D. Cytomegalovirus infection in the acquiredimmunodeficiency syndrome. Clinical and autopsy findings. ArchPathol Lab Med. 1988 May;112(5):540-544. 
  15. Brannagan III TH, Zhou Y. HIV-associated Guillain–Barré syndrome.J Neurol Sci. 2003 Apr;208(1):39-42.
  16. Parry GJ. Peripheral neuropathies associated with humanimmunodeficiency virus infection. Ann Neurol. 1988;23(S1):S49-S53. 
  17. Wagner JC, Bromberg MB. HIV infection presenting with motoraxonal variant of Guillain-Barré Syndrome. Journal of ClinicalNeuromuscular Disease. 2007;9(2):303-305. 
  18. Kolson D. Neurologic Complications of HIV Infection in the Era ofAntiretroviral Therapy. Top Antivir Med. 2017 Jul;25(3):97-101.